Results 121 to 130 of about 5,227,561 (214)
Polycystic kidney disease [PDF]
Policistična je bolest bubrega genetski poremećaj kod kojeg se u bubrezima razvijaju i rastu ciste. Zbog cistama uvećanih bubrega, onemogućena je njihova odgovarajuća funkcija što u konačnici dovodi do zatajenja bubrega, a samim time i do potrebe za ...
Lelas, Judita
core +1 more source
Case Report: Autosomal dominant polycystic kidney disease and Wilms’ tumor in infancy and childhood
BackgroundAutosomal dominant polycystic kidney disease (ADPKD) is rare but one of the most common inherited kidney diseases. Normal kidney function is maintained until adulthood in most patients.
Doviltyte Zina +9 more
doaj +1 more source
ABSTRACT Bile acids (BAs) serve not only as emulsifiers for lipid digestion but also as essential signaling molecules, governing various physiological and pathological processes through their interaction with the farnesoid X receptor (FXR) and the takeda G protein‐coupled receptor 5 (TGR5).
Jie Liu +6 more
wiley +1 more source
Autosomal-dominant polycystic kidney disease (ADPKD) affects up to 12 million individuals and is the fourth most common cause for renal replacement therapy worldwide. There have been many recent advances in the understanding of its molecular genetics and
Torres, Vicente E. +58 more
core +1 more source
Prenatal exome sequencing significantly improves diagnostic yield over chromosomal microarray analysis for fetal CNS abnormalities, with a diagnostic yield of 16% in our cohort and 27% in the meta‐analysis. Diagnostic yields vary across different phenotypes. Abstract Introduction Fetal central nervous system (CNS) abnormalities have diverse etiologies,
Jia Yao +5 more
wiley +1 more source
A Hypertensive Patient With Polycystic Horseshoe Kidney
Adult polycystic kidney disease is transmitted in autosomal dominant pattern with a reported incidence of 1 in 1000 to 1 in 5000 cases. Horseshoe kidney is a renal fusion anomaly with an incidence of 1 in 400 to 1 in 1800 live births.
Alper KIRKPANTUR +3 more
doaj
ABSTRACT Objective Hyponatraemia is a common electrolyte disorder often driven by excess arginine vasopressin (AVP). Copeptin is a stable surrogate marker co‐secreted with AVP. It is unclear whether treatment of hyponatraemia with tolvaptan, an AVP‐V2 receptor antagonist, impacts copeptin.
Annabelle M. Warren +4 more
wiley +1 more source
Management of Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease. In this disease, multiple cysts develop and grow over time in both kidneys.
İsmail Koçyiğit +4 more
doaj +1 more source
IMPROVE 2025: The 3rd International Meeting on Pathway‐Related Obesity: Vision & Evidence
ABSTRACT An international cohort of 161 clinicians and researchers from 19 countries attended the 3rd International Meeting on Pathway‐Related Obesity: Vision & Evidence (IMPROVE) in Prague, Czech Republic, on 2–4 July 2025. The aims of the meeting were to advance understanding of hyperphagia and obesity caused by defects in the melanocortin‐4 receptor
Jesús Argente +17 more
wiley +1 more source
ABSTRACT Background Kidneys from deceased donors with diabetes mellitus are refused because diabetes is considered a marker of lower organ quality. We evaluated 5‐year outcomes according to donor‐recipient diabetes status and, secondarily, the prognostic value of pre‐implantation histopathological findings among accepted diabetic donor kidneys ...
Marina Colella‐Santos +6 more
wiley +1 more source

